Donors who provide funds for endowments such as the Stafford Fellow Program receive satisfaction from the knowledge that their funds live on by providing ongoing funding to help support educating future scientists.
The Stafford Fellowship is a permanent endowment.
For more information on how you can partner with this fund and support graduate education at HWI, please contact Dr. Sarah Smith at 716.898.8636 or email: email@example.com.
Brad Miller PhD
Graduated 2016, Mentor: Andrew Gulick PhD, Thesis title: Structural and functional characterization of nonribosomal peptide synthetases and MbtH-like proteins
Dr. Miller is the Bucher-Jackson Postdoctoral Fellow in the Sciences at Bryn Mawr College in Bryn Mawr, Pennsylvania. He is working on the structural basis of cofactor specificity and feedback inhibition in the mevalonate pathway, best known as the target for statins and other cholesterol lowering drugs. He has produced structural insights into isoprenoid biosynthesis, the largest class of natural products, via X-ray crystallography structure determination and biochemical assays. He has improved the understanding of cofactor binding preference in key enzymes targeted by statins, and trained undergraduates in biochemical and structural laboratory techniques by solving several structures of isoprenoid-producing enzymes bound to ligands and measuring kinetic rates.
Paul Seidler PhD
Graduated 2014, Mentor: Daniel Gewirth PhD, Thesis title: Structural and biochemical studies of GRP94/protein interactions and paralog-specific hsp90 inhibitors
Dr. Seidler took a position as a postdoctoral scholar in the Molecular Biology Institute of the University of California in Los Angeles. He is conducting research on the biochemical and biophysical characterization of tau amyloids and oligomers, important in the understanding and treatment of Alzheimer’s disease.
Kristin Sutton PhD
Graduated 2013, Mentor: Edward Snell, PhD
Dr. Sutton stayed in Buffalo as a postdoctoral researcher at the Institute and then becoming the Laboratory Operations Manager for a small biotech startup company named HarkerBIO. She was one of the first staf at the company.
Today Dr. Sutton is a Senior Project Manager and Senior Scientist at HarkerBIO wearing many hats in a company that has grown by an order of magnitude since she started.
Carter Mitchell PhD
Graduated 2013, Mentor: Andrew Gulick, PhD
Dr. Mitchell took up a position as a postdoctoral research associate in the Department of Chemistry and Biochemistry at the University of Oklahoma (2013-2015). Here he was involved with the development of a bacterial drug discovery pipeline, including isolation, fermentations, and bioactivty assessment. He was also involved with methods development for accessing cryptic biosynthetic operons in bacteria. X-ray crystallography structure solution when applicable.
He moved to the National Cancer Institute (NCI) in Frederick Maryland where he is a postdoctoral research fellow involved in the development and management of the Anticancer Protein Pipeline that identifies bioactive proteins from marine aqueous extract. The project has received the NCI Director’s Innovation award and has identified ~150 extracts with potent and selective anticancer activities.
Kevin Maharaj PhD
Graduated 2012, Mentor: Daniel Gewirth, PhD.
He is currently the Science Department Head, School Data and Assessment Coordinator and Science Advisor at the Eastern University Academy Charter School.
Robert Huether PhD
Graduated 2011, Mentor: William Duax, PhD. Thesis title: Structural and Bioinformatic Studies of Short-Chain Oxidoreductase Enzymes
Dr. Huether took up a position as a postdoctoral fellow in Computational and Structural Biology at St. Jude’s Children’s Research Hospital in Memphis (2011-2014) designing and analyzing a next generation sequencing (NGS) capture study of 1000 paired samples from 21 pediatric cancers based on 633 genes that influence the epigenom. Advanced computational tools used across St. Jude’s to relate cancer associated variants to their function, pathway, and structural alteration.
He moved to Ambry Genetics in Aliso Viejo (2014-2016) as a Computational Structural Biologist leading a group of scientists in combining macromolecular structural analysis, population genetics, and next generation sequencing to understand and classify the functional impact of variants in Mendelian diseases.
Currently he is a senior computational biologist at Tempus Inc. in Chicago.